A | n | P | n | Difference A − P | 95% CI for difference | p value | |
---|---|---|---|---|---|---|---|
Forced expiratory volume in one minute (FEV1) | |||||||
6 h | 14.1 | 25 | 3.7 | 17 | 10.4 | (4.2 to 16.6) | 0.0016 |
12–18 h | 17.1 | 19 | 7.6 | 16 | 9.5 | (2.6 to 16.3) | 0.0082 |
24 h | 22.5 | 22 | 13.1 | 17 | 9.4 | (1.0 to 17.9) | 0.029 |
Maximum mid-expiratory volume (MMEF) | |||||||
6 h | 13.3 | 25 | −0.4 | 17 | 9.3 | (4.3 to 15.7) | 0.0016 |
12–18 h | 13.2 | 19 | 6.9 | 16 | 6.3 | (0.3 to 12.3) | 0.041 |
24 h | 17.1 | 22 | 11.6 | 17 | 5.5 | (−3.0 to 14.1) | 0.2 |
Peak expiratory flow rate (PEFR) | |||||||
6 h | 14.8 | 25 | −0.3 | 17 | 15.1 | (6.5 to 23.7) | 0.001 |
12–18 h | 16.6 | 19 | 6.3 | 16 | 10.3 | (1.7 to 18.9) | 0.02 |
24 h | 22.4 | 22 | 12.2 | 17 | 10.2 | (0.3 to 19.9) | 0.043 |
Group means for FEV1 and PEFR are compared using at test.
For change in MMEF as percentage predicted over first three days, group medians are compared using a Mann-Whitney test, and the difference (A − P) is the point estimate for the difference between medians.
A; aminophylline, P; placebo, n; number of subjects.